IFNG and respiratory tract infectious disorder: In addition, serum levels of the antiviral factor interferon-gamma were significantly increased by 40% after 10 days of CU1 supplementation, compared to baseline within the supplementation group, and decreased risk of respiratory infection was observed in a post hoc analysis, compared to placebo [104].